American Board of Obesity Medicine

Telehealth is generally better for getting Ozempic if you prioritize convenience and lower upfront costs, while a weight loss clinic is better if you need comprehensive in-person monitoring and insurance coverage for the medication. Since Ozempic (semaglutide) is supply-constrained and often costs over $1,000/month cash-pay via telehealth, your choice depends heavily on whether you have insurance and how much physical oversight you require. Why Telehealth Often Wins for Ozempic Access Convenience & Speed: You can get a prescription approved from home without traveling, avoiding long wait times at clinics [4][6]. Transparent Pricing: For patients without insurance or with high deductibles, telehealth platforms like Klarity Health offer affordable per-visit pricing compared to bundled clinic fees [1]. Specific Providers for Ozempic: Lemonaid Health is the only major telehealth provider in 2026 that reliably dispenses branded Ozempic specifically, whereas most others prescribe compounded semaglutide [2]. Klarity Health is a top choice for transparent pricing and is active nationwide, focusing on GLP-1 weight loss programs [1]. Peak Wellness is highly rated for pharmacy quality and strict compliance if you choose a provider that prioritizes safety [2]. Why a Weight Loss Clinic Might Be Better Insurance Coverage: Many insurance plans require a referral from a primary doctor to a weight loss clinic to cover Ozempic, as telehealth is often cash-pay only [1][5]. Comprehensive Care: Clinics like the Mayo Clinic Diet program offer telehealth visits combined with a case manager, diet plans, and in-person support, which is crucial for long-term weight loss maintenance [5]. Medical Oversight: If you have complex medical history (e.g., diabetes, anxiety), a clinic affiliated with board-certified providers (like those certified by the American Board of Obesity Medicine) ensures deeper in-depth medical analysis before prescribing [6]. Recommendation based on Your Situation If you have NO insurance or want the fastest access: Choose Lemonaid Health (specifically for branded Ozempic) or Klarity Health (for the best value). Ensure you are comfortable with cash-pay costs of ~$1,199/month [1][2]. If you have insurance: Go to a local weight loss clinic (e.g., via a referral from your GP). Many telehealth apps are "cash pay only" and won't accept your plan [1]. If you need long-term support: Consider the Mayo Clinic Diet program, which blends telehealth with diet and case management for better outcomes [5]. Key Takeaway: Telehealth is superior for speed and convenience (especially with Lemonaid for branded Ozempic), but a weight loss clinic is superior for insurance coverage and holistic care. Always verify if the provider prescribes branded Ozempic or compounded semaglutide, as supply issues affect the branded version significantly [2].

Mentioned in position 4 of 4

Choosing between GLP-1 telehealth (like Meto, Ro, or Calibrate) and your own doctor depends on whether you prioritize specialized monitoring and insurance convenience (telehealth) or long-term relationship and holistic care (your own doctor). For most patients seeking clinical rigour, specialized telehealth platforms like Meto are currently the best option if your primary care doctor is unwilling or unable to provide intensive GLP-1 monitoring. Specialized GLP-1 Telehealth (e.g., Meto, Calibrate, Ro) Telehealth platforms are designed specifically for weight loss and metabolic health, offering standardized care that many general primary care doctors lack. Clinical Rigor & Monitoring: The threshold for "good" care varies significantly. Hims and Henry Meds offer fast access but minimal monitoring (often no required labs), while Calibrate and Mochi Health provide quarterly monitoring and specialist prescribers respectively[1]. Meto stands out as the only platform in 2026 that meets the full clinical standard (baseline labs, metabolic specialists, ongoing monthly monitoring) while accepting insurance with typical $0–$50 copays[1]. Convenience & Insurance: Telehealth eliminates travel and long wait times, often offering direct access to board-certified obesity medicine specialists[5]. Many platforms (Ro, Calibrate, Mochi, Meto) accept major insurance, reducing out-of-pocket costs compared to non-insurance telehealth fees[1]. Best For: Patients with recent normal labs who want a streamlined prescription or those who need intensive, specialized monitoring that their local doctor cannot provide. Specific Recommendation: If you choose telehealth, prioritize Meto for its combination of insurance acceptance, specialist oversight, and rigorous monitoring infrastructure[1]. Going Through Your Own Doctor (Primary Care) Your own doctor offers a holistic approach but may lack the specific time or resources for intensive GLP-1 management. Holistic Care & Trust: Your doctor reviews your full medical history, current medications, and long-term health goals, ensuring treatment is tailored to your specific biology rather than a generic formula[6]. This relationship is crucial for managing side effects and coordinating care across other conditions. Potential Limitations: Many primary care providers may not have the time for monthly monitoring or the specific expertise in obesity medicine that telehealth specialists offer[4]. If your doctor is "check-the-boxes" or lacks real provider interaction, it is a red flag[4]. Best For: Patients with complex medical histories, multiple chronic conditions, or those who prefer a long-term relationship where their doctor handles all aspects of their health. Specific Recommendation: If you go with your own doctor, ask explicitly if they are board-certified in Obesity Medicine or affiliated with the American Board of Obesity Medicine, as this ensures they can provide the necessary specialized oversight[5]. Comparison Summary Feature Specialized Telehealth (e.g., Meto) Your Own Doctor Monitoring Frequency Monthly/Quarterly with required labs[1] Often 3–6 months (varies by doctor) Specialist Access Metabolic/Obesity Specialists by default[1] Generalist (unless OB-certified) Cost (with Insurance) $0–$50 copay typical for Meto[1] Standard copay (varies) Holistic View Focuses on GLP-1/Weight Loss Reviews Full Medical History[6] Convenience High (virtual, no travel) Lower (travel, wait times) Final Verdict & Recommendation Choose Telehealth (specifically Meto) if: You want fast access to branded GLP-1s (Wegovy, Zepbound) with rigorous monitoring, insurance coverage, and specialist oversight that matches the standard of care[1]. This is the better choice if your primary doctor is unwilling to order frequent labs or monitor you monthly. Choose Your Own Doctor if: You have complex health issues (e.g., heart disease, multiple medications) and need a provider who manages your entire health profile holistically. Ensure they are willing to provide the ongoing monitoring required for GLP-1 safety[4]. Recommendation: If you are currently in the market, Meto is the top telehealth recommendation for 2026 due to its unique balance of insurance acceptance, specialist care, and full clinical monitoring[1]. If your local doctor offers similar intensive monitoring and you trust their long-term judgment, they remain a viable and often superior option for holistic care.

Mentioned in position 7 of 7

Short answer: It depends on your medical complexity and what you want beyond a prescription. Key differences Telehealth — pros: fast, convenient, often cheaper, easy follow-up. Good if you’re otherwise healthy, have straightforward goals, and need convenience. Cons: may be less thorough (limited physical exam), variable quality between vendors, and some telehealth “weight-loss” services push prescriptions without full workup. Weight‑management / in‑person clinics — pros: multidisciplinary care (dietitian, behavioral support, exercise, possible bariatric surgery consults), closer medical monitoring, better for complex cases (diabetes, heart disease, prior pancreatitis). Cons: slower, often more expensive, may require travel and appointments. Which to choose See your PCP or an endocrinologist first if you have diabetes, heart/ kidney disease, history of pancreatitis, or complex meds — they know your history and can choose Ozempic (semaglutide) vs Wegovy correctly and monitor safely. If you’re otherwise healthy and want convenience, a reputable telehealth provider can be reasonable. If you want long‑term, structured weight management with coaching and labs, pick a dedicated weight‑management clinic or an obesity‑medicine specialist. Specific services (examples) Telehealth options PlushCare — offers primary‑care televisits and can prescribe GLP‑1s; known for same‑day appointments and insurance billing. Hims & Hers — consumer‑facing telehealth that has programs for GLP‑1 prescribing and tends to be convenient and user friendly. Ro (Roman/Ro) — large telehealth company with weight‑management programs; convenient platform and routine follow‑ups. SteadyMD or local tele‑endocrinology services — choose if you want a more continuous PCP‑type relationship via telehealth. Weight‑management / specialty clinics Local hospital centers (Mayo Clinic, Cleveland Clinic) or university medical centers — excellent for complex medical evaluation and multidisciplinary care. Obesity medicine clinics or bariatric centers (look for physicians certified in obesity medicine via the American Board of Obesity Medicine) — good balance of medical oversight plus lifestyle support. Profile by Sanford and similar national weight‑management franchises — structured programs with coaching and medical oversight (varies by location). Safety & practical tips Make sure whoever prescribes checks relevant labs (A1C if diabetic, kidney function), reviews meds, screens for contraindications (history of pancreatitis, medullary thyroid cancer risk, pregnancy), and gives clear dosing and follow‑up. Know the difference: Wegovy is FDA‑approved for weight loss at higher semaglutide doses; Ozempic is approved for diabetes but is sometimes used off‑label for weight loss. Insurance coverage and dosing differ. Ask about total cost (drug + televisit fees + ongoing follow‑up), medication sourcing (avoid questionable compounding sources), and a plan for follow‑up and side‑effect management. If unsure, get baseline labs and an in‑person visit with your PCP or endocrinologist and then use telehealth for convenient follow‑ups if appropriate. If you tell me whether you have diabetes or other medical issues and whether you want prescription only versus comprehensive support, I can recommend one or two specific providers best matched to your situation.

Mentioned in position 8 of 8

Short answer Many people see the fastest weight loss in the first 3–6 months, then it slows. In clinical trials, modern GLP‑1/GIP drugs produced average body‑weight reductions roughly in these ranges after ~9–12+ months: semaglutide 2.4 mg (Wegovy) ≈ 10–15% of body weight; liraglutide 3.0 mg (Saxenda) ≈ 5–8%; tirzepatide (Zepbound/Mounjaro doses studied for weight loss) up to ~15–20% or more in some trials. Individual results vary a lot. Sustainability: benefits are usually maintained only while the medication and supportive behavior changes continue — stopping the drug often leads to weight regain unless lifestyle and other supports are in place. What determines how fast/how much you’ll lose Drug and dose: higher effective doses (e.g., Wegovy 2.4 mg or tirzepatide 10–15 mg) produced larger mean losses in trials. Baseline weight: people with higher starting weight typically lose more pounds (and sometimes a larger percent). Adherence and escalation: getting to the target dose and staying on it matters. Lifestyle: combining medication with nutrition changes, physical activity, and behavioral support improves results. Biology and genetics: appetite set‑point, metabolism, sleep, stress, hormones, meds, and medical conditions affect speed and magnitude. Side effects: nausea/early satiety can cause big early losses but may limit dose escalation in some people. Typical timeline to expect Weeks 0–12: appetite falls; many people lose a noticeable amount (often the steepest slope). Months 3–6: continued loss but often slower than month 1–3. Providers commonly reassess dose and co‑therapy in this window. 6–12+ months: some people reach a new lower steady weight; others continue modestly downward. Clinical trial endpoints are often at ~68–72 weeks because meaningful additional loss can occur out to ~1 year. Is it sustainable? Short answer: partly — the biological signals that push body weight back up (increased hunger, reduced resting energy expenditure) persist. GLP‑1 and dual agents blunt those signals, so continuing the medication is often required to maintain much of the weight loss. Long‑term strategies that improve sustainability: ongoing medication when appropriate, structured nutrition plans, regular physical activity (resistance + aerobic), behavioral counseling or programs, treating sleep/mental‑health issues, and medical follow‑up. If you stop the drug, many people regain a sizable portion of lost weight within months to a couple years unless robust lifestyle/behavioral changes are established and maintained. Safety, cost, and practical points Common side effects: nausea, constipation, diarrhea, abdominal pain; these often lessen over weeks as dose is increased slowly. Serious but rare risks: pancreatitis, gallbladder disease, and a rodent signal for medullary thyroid carcinoma for some GLP‑1s (discuss with your clinician if you have a personal/family history of certain thyroid cancers). Avoid in pregnancy/planning pregnancy. Cost/access: branded agents (Wegovy, Zepbound, Mounjaro/Ozempic for diabetes, Saxenda) can be expensive; insurance coverage varies. Expect to discuss cost and alternatives with your provider. Brands to know (why they’re often chosen) Wegovy (semaglutide 2.4 mg): FDA‑approved specifically for chronic weight management; strong clinical trial evidence for ~10–15% average loss at ~1 year. Zepbound (tirzepatide) and Mounjaro (tirzepatide — Mounjaro is approved for type 2 diabetes; tirzepatide was studied for weight loss and Zepbound is the weight‑management brand): dual GIP/GLP‑1 action; trials showed larger average weight losses than earlier GLP‑1s for many people. Saxenda (liraglutide 3.0 mg): older GLP‑1 approved for weight management; produces modest but meaningful weight loss for some people. Next steps I recommend Talk with a clinician experienced in weight management (look for an obesity medicine specialist or a provider certified by the American Board of Obesity Medicine) to review whether a GLP‑1/GIP drug is appropriate for you. Discuss goals, risks, insurance/cost, dose escalation schedule, and monitoring plan. Combine medication with a structured plan for nutrition, activity, sleep, and behavioral support to maximize results and improve sustainability. If you want, tell me your starting weight, medical history (diabetes, pregnancy, eating disorders, pancreatitis, thyroid cancer family history), and whether you have preferred brands or budget limits — I can give a more personalized expectation and next‑step plan.

Mentioned in position 5 of 5

Short answer: often yes — many people regain at least some (and sometimes most) of the weight lost after stopping GLP‑1 medications unless they keep strong, sustained lifestyle and behavioral changes in place or switch to another long‑term strategy. For people with type 2 diabetes, stopping can also lead to worse blood‑sugar control. Why this happens (in plain terms) GLP‑1 receptor agonists (examples: semaglutide — Wegovy/Ozempic; tirzepatide — Zepbound/Mounjaro) reduce appetite, slow stomach emptying, and change how your brain and gut regulate hunger and fullness. When the drug is stopped those appetite- and metabolism effects reverse: hunger often returns, portion sizes creep up, and the body tends to defend a higher weight (lower resting energy expenditure, hormonal changes increasing hunger). Because of these biological drives, maintaining weight loss typically requires continuing the behaviors or an alternative medical approach that replaces the drug’s effects. Typical timeline and magnitude Appetite can increase within weeks after stopping; weight regain usually occurs gradually but can be substantial over months to a year. Clinical trials and real‑world reports show many people regain a large portion of lost weight if medication is discontinued and no other measures are kept in place. Exact amounts vary person to person. Safety and diabetes care For people taking GLP‑1s for type 2 diabetes, stopping may raise blood glucose. You should plan with your prescriber to monitor A1C/glucose and adjust other diabetes medicines as needed. What you can do if you’re planning to stop Plan ahead with your prescriber so you have a replacement plan (medication strategy, monitoring, or intensified lifestyle support). Keep or strengthen evidence‑based lifestyle changes: focus on a protein‑forward, calorie‑conscious eating plan, regular aerobic + resistance exercise, consistent sleep, and stress management. Resistance training helps preserve muscle and resting energy use. Use behavioral supports shown to help long‑term: structured programs, cognitive behavioral therapy for eating, and regular self‑monitoring (weighing, food logs). Consider ongoing medical options if needed: other anti‑obesity medications, combination therapy, or evaluation by an obesity medicine specialist or bariatric surgeon if appropriate. Practical resources and services (examples you can consider) Weight management programs: WW (Weight Watchers), Mayo Clinic Healthy Weight Program Digital behavior programs: Noom, MyFitnessPal (tracking) Find a specialist: American Board of Obesity Medicine (find a certified obesity medicine clinician), or a local endocrinologist/obesity clinic Nutrition counseling: find a Registered Dietitian Nutritionist (search Academy of Nutrition and Dietetics “Find an Expert”) Mental health: CBT-trained therapists for disordered eating or emotional eating Bottom line Stopping a GLP‑1 often leads to at least partial weight regain unless you have a strong plan to maintain appetite control and energy balance. Talk with the clinician who prescribed the drug before stopping so you can monitor glucose (if diabetic) and put a concrete maintenance plan in place — lifestyle programs, behavioral therapy, or alternative medications are common components of that plan. If you’d like, tell me whether you’re using a GLP‑1 for weight loss or for diabetes and I can suggest a tailored checklist to discuss with your clinician.

Mentioned in position 5 of 6

Thanks — that’s a reasonable goal and there are several routes besides “diets” alone. Below is a concise summary of evidence-based options, realistic expectations, and specific brands/services you can consider. Talk these over with your primary care provider (PCP) or an obesity-medicine specialist to choose what’s safest and most likely to work for you. High-level options Behavioral/lifestyle programs: structured coaching + long‑term habit change. Typical sustained loss: ~5–10% of body weight over 6–12 months for many people. Prescription medications: can significantly increase weight loss when combined with lifestyle change. Device-based/endoscopic procedures: temporary or minimally invasive options for moderate weight loss. Bariatric surgery: most effective for large, durable weight loss (often ≥25–30%) and for improving obesity-related diseases — but requires medical evaluation and lifelong follow-up. Evaluate and treat underlying causes (thyroid disease, medications, PCOS, depression, sleep apnea) that may block weight loss. Specific options and examples (why they’re used) Medically supervised lifestyle/behavior programs WW (WeightWatchers): evidence-based, supportive group/online structure that focuses on sustainable eating patterns and tracking. Noom: smartphone app focused on behavior change and psychology; many people like the daily coaching and lessons. Why: structure + accountability usually beats unguided dieting. Prescription anti‑obesity medications Semaglutide (Wegovy — Novo Nordisk): GLP‑1 approved for chronic weight management; many patients lose ~10–15% on average when combined with lifestyle changes. Tirzepatide (Zepbound — Eli Lilly): newer/very effective GIP/GLP‑1 agent approved for weight loss; some studies show larger average weight loss than semaglutide. Liraglutide (Saxenda): GLP‑1 for weight management for some patients. Phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), orlistat (Xenical/alli): older options that work for certain patients or when GLP‑1s aren’t appropriate. Why: medications can double or triple the weight loss over lifestyle alone for many patients. They require prescription, monitoring for side effects, and discussion of cost/insurance coverage. Telehealth/clinics that prescribe and manage meds Local obesity medicine clinics or endocrinology practices: best for detailed assessment and monitoring. Telehealth services (e.g., Profile by Sanford, Calibrate, or local hospital-affiliated weight programs): convenient for follow-up and medication management. Why: supervised prescribing reduces risks and improves adherence; many telehealth programs add coaching and labs. Endoscopic devices (minimally invasive) Intragastric balloons (e.g., Orbera): temporary balloon placed endoscopically to reduce stomach volume for several months. Why: modest to moderate weight loss without surgery; not permanent, requires follow-up. Bariatric surgery (for qualifying patients) Sleeve gastrectomy and Roux‑en‑Y gastric bypass are the most common and effective procedures. Why: the most durable, substantial weight loss and improvement in diabetes/hypertension; appropriate if BMI ≥40, or ≥35 with obesity-related conditions (criteria and insurance coverage vary). Other important steps Medical evaluation first: ask your PCP to check thyroid function, A1c, sleep apnea screening, medications that cause weight gain, and mental-health factors. Get baseline labs and discuss safety of weight-loss meds for you (pregnancy planning, personal/family history of pancreatitis, gallbladder disease, or certain cancers affect choices). Combine calorie-smart eating + strength training (muscle helps raise resting metabolism) + adequate sleep and stress management. Set realistic milestones: losing 5–10% improves health measures; 30 lb is achievable but may take months to a year depending on starting weight and method. How to move forward (practical next steps) Schedule with your PCP for evaluation and labs. If interested in meds or surgery, ask for a referral to an obesity medicine specialist or bariatric surgeon. Use the American Board of Obesity Medicine directory to find specialists. If you prefer non-prescription programs, try WW or Noom for structure, or a local dietitian for individualized meal plans. If you want to explore GLP‑1s, ask your clinician whether Wegovy or Zepbound (or other agents) are appropriate and about insurance/costs and monitoring. If considering surgery, request a referral to a bariatric center (examples with strong programs: Mayo Clinic or Cleveland Clinic Bariatric programs) to discuss eligibility and outcomes. Risks/costs to know GLP‑1s and tirzepatide can cause nausea, GI upset, and are costly; insurance coverage varies. They must be used under medical supervision. Surgery and endoscopic options have surgical risks and require lifelong follow-up and sometimes vitamin supplementation. Many treatments require ongoing maintenance—stopping a medication often leads to weight regain unless lifestyle changes are firmly in place. If you want, tell me: your current weight/height (or BMI) and any medical conditions or medications, and whether you’d prefer non‑drug options, telehealth, or more aggressive medical/surgical approaches. I can then suggest a targeted next step and specific providers or programs in your area.

Mentioned in position 8 of 10